• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向捕获测序检测骨髓瘤免疫球蛋白重排和易位。

Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.

机构信息

University Health Network, Toronto, Canada.

Sunnybrook Health Sciences Centre, Toronto, Canada.

出版信息

Life Sci Alliance. 2022 Nov 3;6(1). doi: 10.26508/lsa.202201543. Print 2023 Jan.

DOI:10.26508/lsa.202201543
PMID:36328595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9644417/
Abstract

Multiple myeloma is a plasma cell neoplasm characterized by clonal immunoglobulin V(D)J signatures and oncogenic immunoglobulin gene translocations. Additional subclonal genomic changes are acquired with myeloma progression and therapeutic selection. PCR-based methods to detect V(D)J rearrangements can have biases introduced by highly multiplexed reactions and primers undermined by somatic hypermutation, and are not readily extended to include mutation detection. Here, we report a hybrid-capture approach (CapIG-seq) targeting the 3' and 5' ends of the V and J segments of all immunoglobulin loci that enable the efficient detection of V(D)J rearrangements. We also included baits for oncogenic translocations and mutation detection. We demonstrate complete concordance with matched whole-genome sequencing and/or PCR clonotyping of 24 cell lines and report the clonal sequences for 41 uncharacterized cell lines. We also demonstrate the application to patient specimens, including 29 bone marrow and 39 cell-free DNA samples. CapIG-seq shows concordance between bone marrow and cfDNA blood samples (both contemporaneous and follow-up) with regard to the somatic variant, V(D)J, and translocation detection. CapIG-seq is a novel, efficient approach to examining genomic alterations in myeloma.

摘要

多发性骨髓瘤是一种浆细胞肿瘤,其特征是克隆性免疫球蛋白 V(D)J 特征和致癌性免疫球蛋白基因易位。随着骨髓瘤的进展和治疗选择,会获得额外的亚克隆基因组改变。基于 PCR 的方法检测 V(D)J 重排可能会受到高度多重反应引入的偏差和体细胞超突变削弱的引物的影响,并且不易扩展到包括突变检测。在这里,我们报告了一种针对所有免疫球蛋白基因座的 V 和 J 段 3'和 5'端的杂交捕获方法(CapIG-seq),该方法能够有效地检测 V(D)J 重排。我们还包括了致癌易位和突变检测的诱饵。我们证明了与 24 个细胞系的匹配全基因组测序和/或 PCR 克隆分型的完全一致性,并报告了 41 个未表征的细胞系的克隆序列。我们还展示了该方法在患者标本中的应用,包括 29 个骨髓和 39 个无细胞 DNA 样本。CapIG-seq 显示了骨髓和 cfDNA 血液样本(同时和随访)在体细胞变异、V(D)J 和易位检测方面的一致性。CapIG-seq 是一种新颖、有效的方法,可用于检查骨髓瘤中的基因组改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/28b920cd24a4/LSA-2022-01543_FigS7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/825dc68210c9/LSA-2022-01543_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/66fc8028c343/LSA-2022-01543_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/0f19eb96a397/LSA-2022-01543_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/95170c6d9766/LSA-2022-01543_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/dead8759cbc5/LSA-2022-01543_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/fcad98cfeb4c/LSA-2022-01543_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/18f4621261f3/LSA-2022-01543_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/684a6d8e5861/LSA-2022-01543_FigS6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/28b920cd24a4/LSA-2022-01543_FigS7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/825dc68210c9/LSA-2022-01543_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/66fc8028c343/LSA-2022-01543_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/0f19eb96a397/LSA-2022-01543_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/95170c6d9766/LSA-2022-01543_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/dead8759cbc5/LSA-2022-01543_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/fcad98cfeb4c/LSA-2022-01543_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/18f4621261f3/LSA-2022-01543_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/684a6d8e5861/LSA-2022-01543_FigS6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/9644417/28b920cd24a4/LSA-2022-01543_FigS7.jpg

相似文献

1
Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.通过靶向捕获测序检测骨髓瘤免疫球蛋白重排和易位。
Life Sci Alliance. 2022 Nov 3;6(1). doi: 10.26508/lsa.202201543. Print 2023 Jan.
2
Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.多发性骨髓瘤的全外显子组测序以鉴定体细胞单核苷酸变异以及涉及免疫球蛋白基因座和MYC的关键易位。
Methods Mol Biol. 2018;1792:71-95. doi: 10.1007/978-1-4939-7865-6_6.
3
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma.多发性骨髓瘤基于 DNA 的微小残留病灶检测中克隆性 V(D)J 序列的基线鉴定。
PLoS One. 2019 Mar 22;14(3):e0211600. doi: 10.1371/journal.pone.0211600. eCollection 2019.
4
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma.多发性骨髓瘤微小残留病灶检测中 V(D)J 测序的捕获率。
Clin Cancer Res. 2022 May 13;28(10):2160-2166. doi: 10.1158/1078-0432.CCR-20-2995.
5
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.单细胞 RNA 测序检测多发性骨髓瘤中的克隆型 V(D)J 重排。
Int J Mol Sci. 2022 Dec 10;23(24):15691. doi: 10.3390/ijms232415691.
6
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.循环肿瘤 DNA 序列分析可替代多发性骨髓瘤骨髓穿刺。
Nat Commun. 2017 May 11;8:15086. doi: 10.1038/ncomms15086.
7
Molecular analysis of immunoglobulin genes in multiple myeloma.多发性骨髓瘤中免疫球蛋白基因的分子分析。
Leuk Lymphoma. 1999 Apr;33(3-4):253-65. doi: 10.3109/10428199909058425.
8
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.对 clonoSEQ 检测方法在急性淋巴细胞白血病、慢性淋巴细胞白血病和多发性骨髓瘤中建立可测量(最小)残留病的分析评估。
BMC Cancer. 2020 Jun 30;20(1):612. doi: 10.1186/s12885-020-07077-9.
9
Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma.多发性骨髓瘤IgH(-)亚组中免疫球蛋白重链蛋白合成缺失的分子特征。
Blood. 2000 Aug 1;96(3):1087-93.
10
Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.多发性骨髓瘤中的免疫球蛋白基因:101例病例系列中的表达和未表达库、重链和轻链配对以及体细胞突变模式
Haematologica. 2006 Jun;91(6):781-7.

引用本文的文献

1
Myeloma mesenchymal stem cells' bioenergetics afford a novel selective therapeutic target.骨髓瘤间充质干细胞的生物能量学提供了一个新的选择性治疗靶点。
Oncogenesis. 2025 Apr 11;14(1):9. doi: 10.1038/s41389-025-00554-5.
2
Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma.多发性骨髓瘤中 CB-6644 抑制 RUVBL1/2 复合物的分子特征。
Int J Mol Sci. 2024 Aug 20;25(16):9022. doi: 10.3390/ijms25169022.
3
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.

本文引用的文献

1
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.全面检测复发性基因组异常:多发性骨髓瘤的靶向测序方法。
Blood Cancer J. 2019 Dec 11;9(12):101. doi: 10.1038/s41408-019-0264-y.
2
High efficiency error suppression for accurate detection of low-frequency variants.高效错误抑制,准确检测低频变异。
Nucleic Acids Res. 2019 Sep 5;47(15):e87. doi: 10.1093/nar/gkz474.
3
CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling.CapTCR-seq:T 细胞受体库分析的杂交捕获。
CREBBP 和 KMT2D 的缺失协同作用加速淋巴瘤的发生并塑造淋巴瘤的免疫微环境。
Nat Commun. 2024 Apr 3;15(1):2879. doi: 10.1038/s41467-024-47012-1.
4
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication.用于淋巴癌预后评估的下一代测序面板的多中心临床交叉验证及变异解读
J Clin Pathol. 2025 Feb 18;78(3):187-194. doi: 10.1136/jcp-2023-209262.
5
An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome.一种用于乙型肝炎病毒转录组长读测序的富集方案和分析流程。
J Gen Virol. 2023 May;104(5). doi: 10.1099/jgv.0.001856.
Blood Adv. 2018 Dec 11;2(23):3506-3514. doi: 10.1182/bloodadvances.2017014639.
4
Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.淋巴瘤中的微小残留病评估:方法与应用
J Clin Oncol. 2017 Dec 1;35(34):3877-3887. doi: 10.1200/JCO.2017.74.5281. Epub 2017 Sep 21.
5
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.循环肿瘤 DNA 序列分析可替代多发性骨髓瘤骨髓穿刺。
Nat Commun. 2017 May 11;8:15086. doi: 10.1038/ncomms15086.
6
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.用于高灵敏度和标准化检测多发性骨髓瘤微小残留病的新一代流式检测技术。
Leukemia. 2017 Oct;31(10):2094-2103. doi: 10.1038/leu.2017.29. Epub 2017 Jan 20.
7
A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma.一种用于检测多发性骨髓瘤中突变、拷贝数变化和免疫球蛋白易位的DNA靶向富集方法。
Blood Cancer J. 2016 Sep 2;6(9):e467. doi: 10.1038/bcj.2016.72.
8
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
9
Sequence capture by hybridization to explore modern and ancient genomic diversity in model and nonmodel organisms.通过杂交进行序列捕获以探索模式生物和非模式生物中的现代和古代基因组多样性。
Nucleic Acids Res. 2016 Jun 2;44(10):4504-18. doi: 10.1093/nar/gkw309. Epub 2016 Apr 21.
10
Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma.多发性骨髓瘤患者细胞遗传学演变的发生率及预后意义
Blood Cancer J. 2016 Mar 11;6(3):e401. doi: 10.1038/bcj.2016.15.